Elanco Scour Formula Extra Powder for Oral Solution

Country: United Kingdom

Language: English

Source: VMD (Veterinary Medicines Directorate)

Active ingredient:

Disodium Hydrogen Citrate, Glucose Monohydrate, Glycine, Potassium Citrate Monohydrate, Potassium Dihydrogen Phosphate, Sodium Chloride, Sodium Citrate Dihydrate

Available from:

Elanco Europe Ltd

INN (International Name):

Disodium Hydrogen Citrate, Glucose Monohydrate, Glycine, Potassium Citrate Monohydrate, Potassium Dihydrogen Phosphate, Sodium Chloride, Sodium Citrate Dihydrate

Pharmaceutical form:

Powder for oral solution

Prescription type:

AVM-GSL - Authorised Veterinary Medicine – General Sales List

Therapeutic group:

Cattle

Therapeutic area:

Replacement Agent

Authorization status:

Authorized

Authorization date:

1993-12-20

Summary of Product characteristics

Revised: October 2020
AN: 00844/2020
Page 1 of 5
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Elanco Scour Formula Extra Powder for oral solution
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE INGREDIENTS
%W/W G/SACHET
SACHET A (Electrolyte mix)
Sodium chloride
5.933
4.59
Glycine
3.891
3.01
Potassium dihydrogen phosphate
1.758
1.36
Sodium acid citrate
2.327
1.80
Potassium citrate monohydrate
4.188
3.24
Sodium citrate dihydrate
0.853
0.66
SACHET B
Glucose monohydrate
81.037
62.69
OTHER INGREDIENTS
Erythrosine E127
(Sachet A)
0.007
0.005
When reconstituted as recommended, it contains;
Glycine
20 mmol/L
Sodium
50 mmol/L
Potassium 20 mmol/L
Chloride 39 mmol/L
Citrate
10 mmol/L
Phosphate 5 mmol/L
Glucose 160 mmol/L
3.
PHARMACEUTICAL FORM
Powder for oral solution.
Presented in a pair sachet containing a pink crystalline powder in
one, and a white
crystalline powder in the other
Revised: October 2020
AN: 00844/2020
Page 2 of 5
4. CLINICAL PARTICULARS
4.1 TARGET SPECIES
Calves
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
As an oral rehydration therapy for the treatment of diarrhoea in
calves by reversing the
process of dehydration, acidosis and loss of electrolytes associated
with diarrhoea,
whether caused by bacteria, viruses, cryptosporidia or inappropriate
nutrition.
4.3 CONTRAINDICATIONS
None.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
4.5 SPECIAL PRECAUTIONS FOR USE
i.
Special precautions for use in animals
None.
ii.
Special precautions to be taken by the person administering the
veterinary
medicinal product to animals
None.
4.6
ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
None known.
4.7
USE DURING PREGNANCY, LACTATION OR LAY
Not applicable.
4.8
INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTION
None known.
The product has been shown to be compatible with oral antibiotics such
as amoxicillin,
ampicillin and oxytetracycline.
4.9 AMOUNTS TO BE ADMINISTERED AND ADMINISTRATION ROUTE
For oral administration only.
Revised: October 2020
AN: 008